Advancing early detection
ScreenHER is building a new category of point-of-care diagnostics platform—designed to deliver rapid, non-invasive detection and enable same-visit care decisions.
Our approach is grounded in a simple premise:
early detection should be accessible, timely, and actionable.
The challenge
Cervical cancer is one of the most preventable cancers—yet women continue to be diagnosed at later stages.
Current screening pathways are multi-step and time-dependent, reliant on lab infrastructure, and dependent on patients returning for follow-up.
From initial screening to follow-up procedures and diagnosis, the process can require multiple visits and extended time between steps.
Each delay increases the risk that patients do not receive the care they need before cancer progresses.
Why this matters now
Healthcare has evolved. Screening has not.
Care is shifting toward decentralized, patient-first models.
Point-of-care diagnostics are now widely accepted across healthcare.
Prevention is increasingly prioritized, yet access gaps remain.
Global health leaders have committed to eliminating cervical cancer.
The infrastructure is ready. The tools must catch up.
Our approach
ScreenHER is developing a rapid, non-invasive diagnostic designed to identify precancer and cancer signals at the point of care.
Our approach enables:
Results in minutes, not weeks
Same-visit care decisions
Integration into real-world clinical workflows
By reducing dependence on lab infrastructure and minimizing the need for repeat visits, early detection becomes more accessible and more actionable.
Platform vision
UriCerve™ is the first application of a broader platform.
ScreenHER is building a scalable diagnostics platform designed to:
Expand access to early detection across care settings
Support decentralized and global screening models
Extend into additional women’s health and oncology applications over time
This platform is supported by a differentiated IP portfolio designed to enable long-term innovation and impact.
Looking ahead
Our focus is to advance toward clinical validation and commercialization through strategic partnerships, regulatory execution, and continued product development.
We are building toward a future where early detection:
Reaches more patients
Happens at the point of care
Requires fewer steps
Leadership
Jennifer is a Purdue-trained mechanical engineer and medtech commercialization leader who has scaled venture-backed platforms from early development to IPO-ready growth.
She has led global strategy and product launches across complex healthcare markets, contributing to the growth of a unicorn-stage medical device company.
She founded ScreenHER to advance a new category of point-of-care diagnostics platform—delivering rapid, patient-centered diagnostics to expand access and improve outcomes for women globally.
ScreenHER
Founder & CEO
Stay in touch
Enter your email address to subscribe to the latest news from ScreenHER.